Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3250 (114th)

DXM Abuse Prevention Act of 2015

openUnited States· United States Congress· EN

Introduced

28 July 2015

Last action

8 July 2016 · Reported

Status

Placed on the Union Calendar, Calendar No. 520.

Sponsors

Rep. Johnson, Bill [R-OH-6], Rep. Matsui, Doris O. [D-CA-7], Rep. Loebsack, David [D-IA-2], Rep. Tonko, Paul [D-NY-20], Rep. Burgess, Michael C. [R-TX-26], Rep. Guthrie, Brett [R-KY-2], Rep. Kinzinger, Adam [R-IL-16], Rep. Barletta, Lou [R-PA-11], Rep. Brownley, Julia [D-CA-26], Rep. Clarke, Yvette D. [D-NY-9], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Huffman, Jared [D-CA-2], Rep. Katko, John [R-NY-24], Rep. Olson, Pete [R-TX-22], Rep. Hastings, Alcee L. [D-FL-20], Rep. Kind, Ron [D-WI-3], Rep. Paulsen, Erik [R-MN-3], Rep. Costello, Ryan A. [R-PA-6], Rep. Meehan, Patrick [R-PA-7], Rep. DeSaulnier, Mark [D-CA-10], Rep. Fitzpatrick, Michael G. [R-PA-8]

Subjects

Healthcare, Defence

Source updated

5 December 2025

Healthcare · Defence

Official sourceDownload fileView documentsShare

Summary

DXM Abuse Prevention Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Civil monetary penalties that escalate upon repeated violation are imposed. To possess or receive unfinished DXM, a person must be registered with the Department of Health and Human Services as a producer of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Unfinished DXM may be distributed only to these authorized persons. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 July 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 28 July 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 July 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 31 July 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

  5. 20 April 2016

    Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Source: Committee

  6. 20 April 2016

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  7. 25 April 2016

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  8. 26 April 2016

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  9. 27 April 2016

    Reported

    Ordered to be Reported by Voice Vote.

    Source: Committee

  10. 27 April 2016

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  11. 8 July 2016

    Calendars

    Placed on the Union Calendar, Calendar No. 520.

    Source: Calendars

  12. 8 July 2016

    Reported

    Reported by the Committee on Energy and Commerce. H. Rept. 114-672.

    Source: Committee

  13. 8 July 2016

    Reported

    Reported by the Committee on Energy and Commerce. H. Rept. 114-672.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

6 official files

Reported in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported in House (text)

    Reported in House · EN · 8 July 2016

    ViewDownloadOpen at official source

  • Reported in House (PDF)

    Reported in House · EN · 8 July 2016

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Reported to House without amendment

    summary · EN · 8 July 2016

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 July 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (PDF)

    Introduced in House · EN · 28 July 2015

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 July 2015

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.